Trident Lifeline SME IPO Recommendations

Pharmaceuticals|SME IPO|BSE SME|

Opened - 26th Sep 2022Closed - 29th Sep 2022Listed - 10th Oct 2022

Should I apply for Trident Lifeline SME IPO?

A total of 1 recommendations were tracked for Trident Lifeline SME IPO. Out of 1 , 0 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 1 for Avoid and 0 hasn't given any rating. In terms of percentage 0% institutes has rated Trident Lifeline SME IPO for subscribe.

₹101.00 per share

Issue Price

IPO Recommendations (0 Reviews)

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	0	0
%	0	0	0	0	0

Last Updated on 13-May-2026 10:31:38